SCHEMBL6860168

SCHEMBL6860168

O=C(O)c1ccccc1C#Cc1ccc(OC(F)(F)F)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN22 Q9Y2R2 2/20 0.51
EPM2A O95278 1/20 0.51
PTPRC P08575 1/20 0.51
PTPN2 P17706 1/20 0.51
PTPN1 P18031 1/20 0.51
PTPRG P23470 1/20 0.51
ACP1 P24666 1/20 0.51
PTPN6 P29350 1/20 0.51
PTPN7 P35236 1/20 0.51
PTPN9 P43378 1/20 0.51
DUSP3 P51452 1/20 0.51
PTPN11 Q06124 1/20 0.51
PTPN13 Q12923 1/20 0.51
DUSP22 Q9NRW4 1/20 0.51
CDC14A Q9UNH5 1/20 0.51
FFAR1 O14842 6/20 0.50
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
DHODH Q02127 1/20 0.46
ACACB O00763 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30607509 0.83 NPC1 (0.67) FFAR1NPC1RAB9AAKR1C2AKR1C1
SCHEMBL28354531 0.81 SLC16A3 (0.54) FFAR1NPC1RAB9AACACB
SCHEMBL6865706 0.81 NPC1 (0.53) PTPN1PTPN6PTPN11FFAR1NPC1
SCHEMBL2256468 0.79 NPC1 (0.72) FFAR1NPC1RAB9AAKR1C2AKR1C1
SCHEMBL29479413 0.79 NPC1 (0.72) FFAR1NPC1RAB9AAKR1C2AKR1C1
SCHEMBL403812 0.79 APP (0.50) PTPN22EPM2APTPRCPTPN2PTPN1
SCHEMBL6866183 0.79 NPC1 (0.57) FFAR1NPC1RAB9AMMP2MMP9
SCHEMBL28287280 0.78 EPHX2 (0.48) DHODHMRGPRX4AKR1C2AKR1C1IGF2BP2
SCHEMBL69187 0.77 NPC1 (0.59) PTPN11FFAR1NPC1RAB9AHNF4A
SCHEMBL29120766 0.76 FFAR1 (0.42) PTPN22EPM2APTPRCPTPN2PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6812252-B2 ACYLSULFONAMIDE DERIVATIVES CONTAINING FLUOROSUBSTITUTEDPHENYLETHYNYL GROUP HAVING A HYPOGLYCEMIC EFFECT AND FREE OF THE SIDE EFFECT AJINOMOTO CO., INC. (JP) 2004-11-02 US disclosed
US-20030181764-A1 Acylsulfonamide derivatives AJINOMOTO CO. INC (JP) 2003-09-25 US disclosed
EP-1316548-A1 ACYLSULFONAMIDE DERIVATIVES Ajinomoto Co., Inc. (JP) 2003-06-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030181764-A1 Acylsulfonamide derivatives DPP4, SLC5A2, GLP1R PTPN22 1123/4885EPM2A 2261/4885PTPRC 2760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.